June 8 (Reuters) – Eledon Pharmaceuticals Inc: * ELEDON ANNOUNCES UPDATED DATA FROM INVESTIGATOR-INITIATED ISLET TRANSPLANT TRIAL OF TEGOPRUBART IN PATIENTS WITH TYPE 1 DIABETES (T1D) AT UCHICAGO
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)